Tissue Regenix Group (TRX)
TRX Share PerformanceMore
|52 week high||21.000 03/01/17|
|52 week low||9.000 20/10/17|
|52 week change||-9.250 (-50.00%)|
|4 week volume||6,220,597 26/09/17|
Latest News« previous» nextMore
18/10/2017 - 07:00 RNS
RNS Number: 8786T Tissue Regenix Group PLC 18 October 2017 [This announcement contains inside information.] Tissue Regenix Group plc Directorate Change Leeds, 18 October 2017 - The Board of Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group") today announces that Antony Odell, Chief Executive Officer (CEO), will be stepping down fro...
11/10/2017 - 07:15 RNS
RNS Number: 2491T Tissue Regenix Group PLC 11 October 2017 Hardman Research: Dual revenue stream growth Dual revenue stream growth - TRX has a broad portfolio of regenerative medicine products developed from decellularised human and porcine soft tissues for the wound care, orthopaedics, and cardiac markets. Since the launch of DermaPure, focus has...
28/09/2017 - 15:15 RNS
RNS Number: 1381S Tissue Regenix Group PLC 28 September 2017 Tissue Regenix Group plc Unaudited Interim Results for the six months ended 30 June 2017 Leeds, 28 th September 2017 - Tissue Regenix Group (AIM:TRX) "Tissue Regenix" or "The Group", the regenerative medical devices company, today announces its unaudited interim results for the six months en...
18/09/2017 - 14:41 Interactive Investor
After a busy summer for Neil Woodford, David Brenchley reveals what the star fund manager bought and sold last mon...
08/09/2017 - 07:00 RNS
RNS Number: 2015Q Tissue Regenix Group PLC 08 September 2017 Tissue Regenix Group plc Notice of Interim Results and Capital Markets Day Leeds, 8 September 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, today gives notice that it will announce its interim results for the six months ending...
05/09/2017 - 15:52 RNS
RNS Number: 8912P Tissue Regenix Group PLC 05 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue R...
30/08/2017 - 17:15 RNS
RNS Number: 3527P Tissue Regenix Group PLC 30 August 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 30 August 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 711,083 ordinary shares of 0.5p each in the Compan...
16/08/2017 - 12:22 RNS
RNS Number: 1729O Tissue Regenix Group PLC 16 August 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tissue Rege...
|Dividend yield||0 %|
Latest discussion posts More
“Well its never positive to not have mutually agreed and beneficial outcomes (and statement) as a shareholder you want to think the company has some integrity.More importantly ...”▼
“Market likes it - share currently up. Has he been the one holding things back - could be a 'my baby' syndrome and would not release the reins. Will watch before dipping toe”▼
“With immediate effect. No explanation. One wonders how this can be viewed as transparency. Even if they?d just said ?personal reasons? ! Poor PR. Unlike this company. Some ...”▼
Codes & Symbols
|Symbols||TRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX|